|
Related Companies
|
[]
|
||||||||
|
Related Funds
|
[]
|
||||||||
|
|
|||||||||
|
English
|
|||||||||
|
oda_MaterialEventDisclosureGeneralAbstract|
|
|
||||||||
|
oda_UpdateAnnouncementFlag|
|
|
Hayır (No)
|
|||||||
|
oda_CorrectionAnnouncementFlag|
|
|
Hayır (No)
|
|||||||
|
oda_DateOfThePreviousNotificationAboutTheSameSubject|
|
|
-
|
|||||||
|
oda_DelayedAnnouncementFlag|
|
|
Hayır (No)
|
|||||||
|
oda_AnnouncementContentSection|
|
|
||||||||
|
oda_ExplanationSection|
|
|
||||||||
|
oda_ExplanationTextBlock|
|
-Unofficial Translation- Gen İlaç ve Sağlık Ürünleri Sanayi ve Ticaret A.Ş. (GEN) has decided to participate in the capital increase carried out by Gen Pharma Caucasus Manufacturing Operations MMC (GEN Caucasus), a company in which GEN holds a 66% ownership stake. As a result of the capital increase, GEN Caucasus's capital has been raised to 15,300,000 AZN (Fifteen Million Three Hundred Thousand Azerbaijani Manat). GEN's ownership percentage has been maintained at 66%. |
||||||||